Mercia Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Tagomics develops multimodal technologies for precision medicine and next-generation diagnostics.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, GB
Dr Jack Kennefick(Co-founder, Director & Chief Executive Officer)Dr Robert Neely(Co-founder, Director & Chief Scientific Officer)
Co-investorsIllumina VenturesCalculusCalculus Capital Ltd.IQ CapitalMEIF Proof-of-Concept & Early Stage FundOMX Ventures+1 more
Wobble Genomics operates an RNA sequencing platform that captures full-length RNA transcripts to identify long RNA biomarkers and novel isoforms for precision medicine.
BiotechDeep TechDigital HealthHealthtechMedical DevicesEdinburgh
Richard Izen Kuo(Executive Officer, Director)Joanna Smart(Director)Lee James Lindley(Director)John Harris Leamon(Director)Trevor John Nicholls(Director)John Robert Fraser Duncan(Director)
Co-investorsEos AdvisoryIQ CapitalOld College Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.